Innate Pharma announces conference call and webcast for Q1 2026 Business Update

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), today announces that the Company will hold a conference call on Wednesday, May 13, 2026 at 1:30 p.m. CEST / 7:30 a.m. EDT, to provide an update on business progress for the first quarter of 2026.

Participants during the call will be: 

• Jonathan Dickinson, Chief Executive Officer
• Sonia Quaratino, Executive Vice President, Chief Medical Officer
• Yannis Morel, Executive Vice President, Chief Operating Officer
• Stéphanie Cornen, Vice President, Investor Relations, Communication & Commercial strategy
• Frédéric Lombard, Senior Vice President, Chief Financial Officer

Event Details
The live webcast will be available at the following link: 
https://events.q4inc.com/attendee/211092666

Participants may also join via telephone using the following registration link: https://events.q4inc.com/analyst/211092666?pwd=nO162IiF

This information is also available on the Investors section of the Innate Pharma website, www.innate-pharma.com. A replay of the webcast will be available on the Company website for 90 days following the event.